Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of Tirzepatide

A technology of resin and peptide resin, which is applied in the field of peptide drug preparation, can solve the problems of low product purity, reduce the difficulty of purification, improve the purity of crude products, and achieve the effects of wide practical value and application prospects

Pending Publication Date: 2020-03-24
CHENGDU SHENGNUO BIOPHARM
View PDF7 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The invention provides a new high-efficiency preparation method, adopts a special protected amino acid fragment, and solves the problem of low product purity in the large-scale preparation method

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of Tirzepatide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] The synthesis of embodiment 1 Tirzepatide peptide resin

[0032] Tirzepatide Peptide Resin:

[0033] Boc-Tyr(tBu)-Aib-Glu(OtBu)-Gly-Thr(tBu)-Phe-Thr(tBu)-Ser(tBu)-Asp(OtBu)-Tyr(tBu)-Ser(tBu)-Ile- Aib-Leu-Asp(OtBu)-Lys(Boc)-Ile-Ala-Gln(Trt)-Lys(AEEA-AEEA-γGlu-Eicosanedioic acid(mon-tBu))-Ala-Phe-Val-Gln(Trt) -Trp(Boc)-Leu-Ile-Ala-Gly-Gly-Pro-Ser(tBu)-Ser(tBu)-Gly-Ala-Pro-Pro-Pro-Pro-Ser(tBu)-aminoresin

[0034]Using Rink Amide MBHA resin as the starting resin, Tirzepatide peptide resin was prepared by de-Fmoc protection and coupling reaction, followed by coupling with the protected amino acids shown in Table 2. The protected amino acids or fragments corresponding to the protected amino acids used in this example are as follows:

[0035] Table 2

[0036] The peptide sequence n= Protected Amino Acids 1 Fmoc-Ser(tBu) 2 Fmoc-Pro 3 Fmoc-Pro 4 Fmoc-Pro 5 Fmoc-Ala 6 Fmoc-Gly 7 Fmoc-Ser(tBu) 8 Fmoc-Ser(tBu) 9 F...

Embodiment 2

[0043] The preparation of embodiment 2 Tirzepatide crude product

[0044] Take the Tirzepatide peptide resin prepared in Example 1, add a cleaving reagent with a volume ratio of TFA:water:EDT=95:5:5 (cracking reagent 10mL / gram of resin), stir evenly, stir at room temperature for 3 hours, and use the reaction mixture Filter with sand core funnel, collect the filtrate, wash the resin 3 times with a small amount of TFA, combine the filtrates and concentrate under reduced pressure, add anhydrous ether to precipitate, then wash the precipitate with anhydrous ether 3 times, and drain to obtain off-white powder which is the crude product of Tirzepatide , the crude product purity is 72.7%.

Embodiment 3

[0045] Embodiment 3 The purification of Tirzepatide crude product

[0046] Take the crude Tirzepatide obtained in Example 2, add water and stir, adjust the pH to 8.5 with ammonia water until completely dissolved, filter the solution with a 0.45 μm mixed microporous membrane, and purify it for later use;

[0047] High-performance liquid chromatography was used for purification, and the chromatographic filler for purification was 10 μm reversed-phase C18. Two mobile phase systems were used for purification alternately. The first mobile phase system was 0.1% TFA / water solution-0.1% TFA / acetonitrile solution, and the second mobile phase system was 0.1% TFA / water solution-0.1% TFA / acetonitrile solution. The two mobile phase systems are 50mmol ammonium acetate / water solution-acetonitrile. The flow rate of the 77mm*250mm chromatographic column is 90mL / min, the gradient system is used for elution, and the sample is injected and purified in a circular manner. The crude product solution...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a preparation method of Tirzepatide. The preparation method adopts special protection amino acids: Boc-Tyr(tBu)-Aib-Glu(OtBu)-Gly-OH and Fmoc-Lys(AEEA-AEEA-gamma Glu(alpha-OtBu)-Eicosanedioicacid(mon-tBu))-OH, and solves the problem of low product purity in large-scale preparation methods.

Description

technical field [0001] The invention belongs to the technical field of polypeptide drug preparation methods, in particular to a preparation method of Tirzepatide. Background technique [0002] Tirzepatide is a GIP and GLP-1 dual agonist. Tirzepatide can improve β-cell function and improve insulin sensitivity, thus demonstrating its efficacy; Double improvement in efficacy and tolerability; After 8 weeks of treatment with Tirzepatide, A1C and body weight in Japanese patients with type 2 diabetes were significantly reduced; Tirzepatide can treat nonalcoholic steatohepatitis (NASH, liver inflammation and Improvement in markers of cell damage caused by fat). "These new Tirzepatide data build on the positive results of studies conducted to date in patients with type 2 diabetes and provide additional evidence of the benefits of Tirzepatide on A1C and body weight levels in patients with type 2 diabetes. Significant reduction, while the drug can also treat other metabolic diseases...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/00C07K1/06C07K1/04C07K1/16
CPCC07K14/001Y02P20/55
Inventor 郭德文曾德志文永均
Owner CHENGDU SHENGNUO BIOPHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com